Sterling Biotech Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Dec' 18	Sep' 18	Dec' 17	Sep' 17	Jun' 17

Sales

94.95

81.96

87.05

88.51

94.82

Operating profit

11.34

12.41

3.36

6.51

0.49

Interest

-102.33

147.50

111.48

112.06

102.52

Gross profit

114.35

-133.27

-106.58

-103.32

-100.78

EPS (Rs)

1.36

-5.00

-6.17

-6.05

-4.02

Other income

0.68

1.83

1.54

2.23

1.25

Stock adjustment

2.02

0.32

3.47

3.54

3.45

Raw material

62.71

51.40

59.12

58.21

68.75

Power and fuel

-

-

-

-

-

Employee expenses

12.60

12.10

14.71

13.48

13.55

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

6.28

5.72

6.39

6.76

8.58

Provisions made

-

-

-

-

-

Depreciation

61.47

61.46

56.20

61.44

66.68

Taxation

15.91

-58.59

-

-

-57.95

Net profit / loss

36.97

-136.13

-168.02

-164.76

-109.50

Extra ordinary item

-

-

-5.24

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

27.22

27.22

27.22

27.22

27.22

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

11.94

15.15

3.86

7.36

0.52

GPM (%)

119.58

-159.06

-120.32

-113.87

-104.90

NPM (%)

38.66

-162.48

-189.67

-181.58

-113.98